March 26, 2019

In a consent judgment, Purdue Pharma will pay a total of $270 million to the State of Oklahoma to resolve charges that the company illegally marketed its opioid pain medications by overstating their efficacy and falsely downplaying the risk of addiction.  OK

Tagged in: Off-Label and Unapproved Use, Pharma Fraud,